<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pain</journal-id><journal-id journal-id-type="iso-abbrev">Pain</journal-id><journal-id journal-id-type="coden">JPAIN</journal-id><journal-id journal-id-type="pmc">Pain</journal-id><journal-id journal-id-type="publisher-id">JOP</journal-id><journal-title-group><journal-title>Pain</journal-title></journal-title-group><issn pub-type="ppub">0304-3959</issn><issn pub-type="epub">1872-6623</issn><publisher><publisher-name>Wolters Kluwer</publisher-name><publisher-loc>Philadelphia, PA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7302093</article-id><article-id pub-id-type="publisher-id">PAIN-D-20-00466</article-id><article-id pub-id-type="doi">10.1097/j.pain.0000000000001950</article-id><article-id pub-id-type="art-access-id">00003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Topical Review</subject></subj-group></article-categories><title-group><article-title>Considering the potential for an increase in chronic pain after the COVID-19 pandemic</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Clauw</surname><given-names>Daniel J.</given-names></name><xref ref-type="aff" rid="aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>H&#x000e4;user</surname><given-names>Winfried</given-names></name><xref ref-type="aff" rid="aff2">b</xref><xref ref-type="aff" rid="aff3">c</xref></contrib><contrib contrib-type="author"><name><surname>Cohen</surname><given-names>Steven P.</given-names></name><xref ref-type="aff" rid="aff4">d</xref><xref ref-type="aff" rid="aff5">e</xref></contrib><contrib contrib-type="author"><name><surname>Fitzcharles</surname><given-names>Mary-Ann</given-names></name><xref ref-type="aff" rid="aff6">f</xref><xref ref-type="aff" rid="aff7">g</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="aff1"><label>1</label><sup>a</sup>Departments of Anesthesiology, Medicine (Rheumatology), and Psychiatry, Chronic Pain and Fatigue Research Center, the University of Michigan Medical School, Ann Arbor, MI, <country>United States</country></aff><aff id="aff2"><label>b</label>Department of Psychosomatic Medicine and Psychotherapy, Technische Universit&#x000e4;t M&#x000fc;nchen, M&#x000fc;nchen, <country>Germany</country></aff><aff id="aff3"><label>c</label>Department Internal Medicine I, Klinikum Saarbr&#x000fc;cken, Saarbr&#x000fc;cken, <country>Germany</country></aff><aff id="aff4"><label>d</label>Department of Anesthesiology and Critical Care Medicine, Neurology and Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, Maryland, <country>United States</country></aff><aff id="aff5"><label>e</label>Uniformed Services University of the Health Sciences, Bethesda, MD, <country>United States</country></aff><aff id="aff6"><label>f</label>Department of Rheumatology, McGill University, Montreal, QC, <country>Canada</country></aff><aff id="aff7"><label>g</label>Alan Edwards Pain Management Unit, McGill University, Montreal, QC, <country>Canada</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Address: Montreal General Hospital, McGill University Health Centre, 1650 Cedar Ave, Montreal, QC, H3G 1A4. Tel.: (514)-934-1934#44176; fax: (514)-934-8239. E-mail address: <email>mary-ann.fitzcharles@muhc.mcgill.ca</email> (M.-A. Fitzcharles).</corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>03</day><month>6</month><year>2020</year></pub-date><volume>161</volume><issue>8</issue><fpage>1694</fpage><lpage>1697</lpage><history><date date-type="received"><day>20</day><month>4</month><year>2020</year></date><date date-type="rev-recd"><day>29</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>02</day><month>6</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" specific-use="CCBY-NC-ND"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)</ext-link>, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</license-p></license></permissions><self-uri xlink:href="jop-161-1694.pdf"/><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>1. Introduction</title><p>The COVID-19 pandemic has impacted the lives and health of persons worldwide, with potential for further effects in the future. The experience of living within this pandemic has disrupted daily life across all sectors, including those living with chronic pain (CP), those infected with the coronavirus Severe Acute Respiratory Syndrome (SARS)-CoV2, healthcare providers and essential workers, as well as those who remained physically healthy. The toll of this pandemic extends beyond physical illness, with important psychosocial stressors that include prolonged periods of limited interpersonal contact, isolation, fear of illness, future uncertainty, and financial strain. Uncertainty is fuelled by the constant media coverage, often with conflicting information, differing recommendations by public health authorities in different jurisdictions, and the unknown duration and likelihood of resurgence of this pandemic. In this context, we will examine the potential health consequences of COVID-19 germane to CP, which might be nociplastic, neuropathic, or nociceptive. Specific possibilities might include: (1) CP as part of a postviral syndrome or the result of viral-associated organ damage; (2) worsening of CP due to exacerbation of preexisting pain physical or mental complaints; and (3) CP newly triggered in individuals not infected with COVID by exacerbation of risk factors (poor sleep, inactivity, fear, anxiety, and depression).</p><p>Chronic pain must be considered in the context of the biopsychosocial model, which views symptoms as the result of a complex and dynamic interaction between biological, psychological, and social factors.<sup><xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R39" ref-type="bibr">39</xref></sup> Underlying predisposing mechanisms include genetic factors, previous pain experience, and traumatic events that could be physical or emotional.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Chronic pain conditions can be triggered by psychosocial stressors or organ-specific biological factors, which may preferentially occur in individuals with a fragile stress response system.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R47" ref-type="bibr">47</xref></sup> The COVID-19 pandemic has many characteristics that could potentially increase the prevalence of CP, especially with stressors extending over many months.</p><p>The worldwide pain community is invited to consider the possible downstream consequences of COVID-19, not only for patients surviving infection, but also for the wider community that has experienced psychological, social, and economic effects. Although we address these issues from the perspective of physicians practicing in developed countries, many of the consequences discussed will be particularly relevant for people in other countries, with a call for colleagues in Asia, Africa, and South America to enter into this dialogue.</p></sec><sec id="s2"><title>2. Infections as a trigger for chronic pain</title><p>Acute viral illnesses often present with myalgia and fatigue, as well as organ-specific symptoms, as seen with influenza, and noted in the H1N1 pandemics of 1918 and 2009, and coronavirus infection during the SARS epidemic.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R17" ref-type="bibr">17</xref></sup> Outcomes related to these infections are almost always focused on the immediate response to the acute illness, with little attention to long-term outcomes. In a small study of 22 subjects (21 of whom were healthcare workers) infected during the SARS epidemic, a chronic post-SARS syndrome consisting of fatigue, diffuse myalgia, depression, and nonrestorative sleep persisted for almost 2 years.<sup><xref rid="R27" ref-type="bibr">27</xref></sup> Similarly, some patients with chronic widespread pain report onset of symptoms after a perceived viral illness.</p><p>Although some infections cause specific postinfectious syndromes, there is also a common stereotypical response to any type of infection that is often observed. For example, up to 12% of patients infected with 3 different pathogens, ie, <italic>Ross River virus</italic> (the cause of epidemic polyarthritis), <italic>Coxiella burnetii</italic> (cause of Q fever), and Epstein&#x02013;Barr virus, experienced a postviral syndrome of pain, fatigue, and memory difficulties for up to 12 months after infection.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Although these infections have markedly disparate acute presentations, a stereotypical chronic syndrome occurred at remarkably similar rates and was not predicted by demographic, psychological/psychiatric measures, or microbiological factors.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> The presence and severity of somatic symptoms during acute infection was closely correlated with the subsequent development of chronic fatigue and pain.</p><p>Chronic regional pain and other somatic symptoms can follow other types of acute infection. In a meta-analysis, Halvorson et al. noted that approximately 10% of individuals will develop postinfectious irritable bowel syndrome after an episode of acute viral or bacterial gastroenteritis, with premorbid psychological problems and/or psychosocial stressors recognized as risk factors.<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> On a similar note, an episode of acute urinary tract infection is evident in a substantial proportion of women who develop interstitial cystitis/painful bladder syndrome.<sup><xref rid="R43" ref-type="bibr">43</xref></sup></p><p>Collectively, these findings imply that various acute infections are capable of triggering both widespread and regional CP. The evidence also suggests that the inciting infection must be of sufficient severity and duration to disrupt normal activities.<sup><xref rid="R44" ref-type="bibr">44</xref></sup> Current estimates are that 80% of laboratory-confirmed COVID-19 patients have mild to moderate disease, including both pneumonia and nonpneumonia cases, 13.8% have severe disease, and 6.1% develop critical illness requiring intensive care unit (ICU) admission.<sup><xref rid="R42" ref-type="bibr">42</xref></sup></p></sec><sec id="s3"><title>3. Potential health-related consequences of COVID-19</title><sec id="s3-1"><title>3.1. Chronic pain as a consequence of COVID-19 disease</title><p>Persons with COVID-19 may exhibit a broad range of symptoms, beginning with those who are asymptomatic and extending to patients who develop full-blown severe respiratory distress syndrome. Nonspecific constitutional symptoms include fatigue, myalgias, chills, and headaches. Most patients experience symptoms for 1 to 2 weeks with complete resolution, although some require hospitalization. The mortality rate of COVID-19 is on the order of 1% according to estimates published by the Centre for Evidence-Based Medicine.<sup><xref rid="R37" ref-type="bibr">37</xref></sup> Whether patients with CP are more susceptible to viral infection or the consequences thereof is unknown. Theoretically, the diminished immune response system observed in CP patients could be even further suppressed by factors such as depression, poor sleep, and opioid use, with potential to increase susceptibility to SARS-CoV2.<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R41" ref-type="bibr">41</xref></sup></p><p>Many individuals with COVID need ICU care, and individuals surviving an illness requiring ICU admission are at increased risk of long-lasting severe functional limitations, psychological distress, and CP. Surveys have reported persistent CP in 38% to 56% of ICU survivors when evaluated 2 to 4 years after ICU admission.<sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup> Quality of life can also be affected for prolonged periods. In a study evaluating 575 patients 6 to 11 years after ICU discharge, many experienced persistent difficulty with mobility (52%), self-care (19%), activities of daily living (52%), pain/discomfort (57%), and cognition (43%).<sup><xref rid="R38" ref-type="bibr">38</xref></sup></p><p>Mental health is also frequently affected by severe illness. Between 41% and 65% of SARS survivors have experienced persistent psychological symptoms.<sup><xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> Between 25% and 44% of Hong Kong residents who were infected with SARS and survived were diagnosed with posttraumatic stress disorder (PTSD), and 15% experienced depression for at least 30 months after the illness.<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R22" ref-type="bibr">22</xref></sup> Posttraumatic stress disorder also occurred in 40.7% of SARS-infected healthcare workers.<sup><xref rid="R22" ref-type="bibr">22</xref></sup></p></sec><sec id="s3-2"><title>3.2. Exacerbation of chronic pain in the absence of actual infection</title><p>Some CP patients may experience exacerbation of symptoms resulting from COVID-19 due to both public health and personal issues. Regular medical care may be compromised during lockdown and the ensuing months.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> Routine clinics may be less accessible or closed, healthcare professionals may be diverted to COVID-19-related activities, and waiting times may be prolonged, especially for medical illnesses such as CP that many consider nonurgent. Patients may be less able or willing to travel for care, or may be fearful of exposure to infection in a public or medical setting. There may be delays in timely access to medications due to reduced prescribing, as well as to pain management procedures considered to be of lesser importance than the care of patients with more urgent illnesses. Reduced clinical encounters with interdisciplinary healthcare team members (eg, physiotherapists, psychologists, and self-help groups) can have adverse consequences. Access to medications may be reduced due to logistical factors or true drug shortages when analgesic medications are diverted to emergency care causing some to turn to alcohol or nonmedically prescribed substances as a desperate measure to relieve poorly managed pain. The rapid evolution of telehealth presents new challenges for clinical care, especially for those not fully comfortable with or without access to digital technology. The economic impact on public health is evident for working patients who may have lost jobs or health insurance and must contend with financial insecurity or even poverty. Another factor to consider is reduced health-related physical activities, which are a vital management strategy for CP, that result from social distancing and isolation, and closure of group activity programs such as gyms and pools.<sup><xref rid="R21" ref-type="bibr">21</xref></sup> Limited social support will also contribute to poor psychological health.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Patients may have a heightened awareness of physical symptoms accompanied by fear that these symptoms are an indication of infection. These numerous and persistent stressors may exacerbate pain, even in the absence of viral illness.</p><p>Given these factors, common wisdom might suggest that catastrophic and stressful events such as COVID-19 will inevitably lead to an exacerbation of CP. However, 2 studies performed in the United States just before and after the 9/11 terrorist attacks indicate that not all psychological stressors will trigger or exacerbate CP. Pain complaints and other somatic symptoms did not change among residents of New York and New Jersey who had been surveyed before and after the 9/11 attacks on the World Trade Center.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> Similarly, pain complaints did not change for patients with fibromyalgia in the Washington, D.C. region during the same period.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> Daily &#x0201c;hassles&#x0201d; and personally relevant stressors seem to be more likely to cause symptoms than major catastrophic events that do not personally impact the individual.<sup><xref rid="R30" ref-type="bibr">30</xref></sup> Therefore, the duration of the stress (ie, weeks to months of lockdown in the current pandemic), and the vocational uncertainty and actual loss of jobs, may adversely affecting health outcomes.</p><p>Reviews that highlight the role that various catastrophic events have on health suggest a number of factors that may be more important than the intensity of the &#x0201c;stressor&#x0201d; in predicting adverse health outcomes. Female sex, concerns about or the expectation of chronicity, and inactivity or time off work can all trigger pain and other somatic symptoms.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> Naturally occurring catastrophic events such as earthquakes, floods, or fires seem less likely to lead to chronic somatic symptoms than similarly &#x0201c;man-made&#x0201d; stressful events such as chemical spills or war.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Exposure to a multitude of stressors simultaneously, or over time, may also pose significant risk for later somatic and/or psychological sequelae.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R33" ref-type="bibr">33</xref></sup> For example, in military personnel, multiple deployments significantly increase the risk for PTSD and other psychiatric conditions, which in turn are highly coprevalent with CP.<sup><xref rid="R46" ref-type="bibr">46</xref></sup></p></sec><sec id="s3-3"><title>3.3. New onset of chronic pain related to psychological stressors</title><p>It is not currently known whether COVID-19 will cause an increase in new-onset CP for the population at large. Risk factors for the longitudinal development of CP have been well studied in fibromyalgia and temporomandibular disorders.<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup> Although CP conditions are thought by some to be highly related to stress and distress, studies have consistently shown that high baseline levels of psychological distress are only modestly related to the development of chronic regional or widespread pain (OR 1.5-2).<sup><xref rid="R25" ref-type="bibr">25</xref></sup> Regional CP, female sex, and low socioeconomic status are the strongest predictors for the subsequent development of widespread pain.<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R25" ref-type="bibr">25</xref></sup> Other factors that may contribute to an increase in CP are poor sleep and reduced physical activity. Sleep deprivation can lead to symptoms virtually indistinguishable from widespread pain, fatigue, and diffuse tenderness.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> Furthermore, the effects of sleep deprivation may be attenuated by physical activity (ie, individuals who remain physically active may be less sensitive to the effects of sleep disruption).<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Healthcare workers may be at increased risk for development of CP. In a recent Israeli study, 9.7% of a cohort of 206 nurses fulfilled criteria for fibromyalgia, with symptoms strongly correlated with work-related stress and PTSD-related symptoms.<sup><xref rid="R3" ref-type="bibr">3</xref></sup></p><p>Numerous factors contribute to high stress levels across geographic boundaries. Nearly everyone is exposed to relentless media coverage and conflicting messages, and concerns about contracting SARS-CoV2, routine medical care, family, jobs, and economic issues are pervasive. Those with an underlying mental health disorder are at particular risk for exacerbation. Further stressors relate to social distancing, isolation and quarantine, and in some, grieving a death without the usual social support system. Persistent and extreme stress can lead to severe mental health consequences including an increased suicide rate. There is preliminary evidence that anxiety and depression (16%-28%), self-reported stress (8%), and sleep disturbances are common reactions to this pandemic.<sup><xref rid="R31" ref-type="bibr">31</xref></sup> During the SARS outbreak in 2003, an historically high suicide rate of 18.6 per 100,000 was reported in Hong Kong.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Furthermore, the annual suicide rate in older adults after the SARS epidemic did not return to preepidemic levels, suggesting that factors related to the epidemic had long-term consequences.</p></sec></sec><sec id="s4"><title>4. Immediate consequences of COVID-19 and strategies to mitigate these effects</title><p>Recovery from a life-threatening illness can be expected to affect future physical and mental health. Rehabilitation services should be mobilized for both inpatient and outpatient care, with attention paid to staffing issues to ensure access to psychological services, physiotherapy, and occupational therapy.<sup><xref rid="R35" ref-type="bibr">35</xref></sup> Routine medical care will resume for most patients, and healthcare professionals should be flexible and willing to adapt to new methods of healthcare delivery, especially with regard to telemedicine.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> Healthcare workers must also adapt to different methods of communicating with colleagues and an increased emphasis on virtual learning and teaching. Those working in mental health must be attuned to the consequences of economic hardship, which could include increased substance abuse, domestic violence, and suicide. Providers working in low- and middle-income countries are particularly disadvantaged by limited healthcare resources and a shortage of healthcare workers.<sup><xref rid="R45" ref-type="bibr">45</xref></sup> Developed countries should recognize that healthcare crises in underdeveloped countries are constrained by artificial boundaries and continue to participate in efforts led by international organizations such the World Health Organization and International Red Cross. These suggestions can only be implemented if governments and legislators are willing to work in partnership with the healthcare community in accordance with the recommendations of experts.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In this unprecedented crisis, the immediate healthcare concerns are directed towards containment and acute patient care. The impact of the COVID-19 pandemic on health will likely be manifested in both infected individuals and in people spared infection, but are nevertheless adversely affected by disruptions in normal life and experience a wide array of physical, psychological, and social stressors. Based on past experience, we postulate that these scenarios may collectively lead to an increase in CP in the immediate and possibly long-term future. Amidst many uncertainties, the research community is urged to study, devise, and implement strategies aimed at mitigating the pain-related health consequences of this pandemic. Some suggestions could include the establishment of registries of infected patients (including those with concomitant CP), designated COVID-19-related clinics to ensure new and follow-up care for infected persons, examination of telehealth as a means of delivering health care, and population surveys to gather public health information related to COVID-19. Epidemiological data should be used to inform future healthcare policies that seek to reduce the magnitude of future epidemics and their myriad consequences on CP and other diseases. The timely recognition of new CP or exacerbations of preexisting CP, prompt and targeted treatment, and strategies to mitigate the potential impact on health are strongly encouraged.</p></sec><sec sec-type="COI-statement"><title>Conflict of interest statement</title><p>D.J. Clauw has performed consulting for Pfizer, Tonix, Samumed, Lilly, and Aptinyx, and has received research funding from Aptinyx. S.P. Cohen is supported by a grant from the U.S. Dept. of Defense, Uniformed Services University, Department of Physical Medicine &#x00026; Rehabilitation, Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) (HU00011920011). The remaining authors have no conflicts of interest to declare.</p></sec></body><back><ack><title>Acknowledgements</title><p>All authors participated in the writing of this manuscript.</p></ack><fn-group><fn fn-type="COI-statement"><p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ablin</surname><given-names>JN</given-names></name><name><surname>Clauw</surname><given-names>DJ</given-names></name><name><surname>Lyden</surname><given-names>AK</given-names></name><name><surname>Ambrose</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>DA</given-names></name><name><surname>Gracely</surname><given-names>RH</given-names></name><name><surname>Glass</surname><given-names>JM</given-names></name></person-group>
<article-title>Effects of sleep restriction and exercise deprivation on somatic symptoms and mood in healthy adults</article-title>. <source>Clin Exp Rheumatol</source>
<year>2013</year>;<volume>31</volume>(<issue>6 suppl 79</issue>):<fpage>S53</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">24373363</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afari</surname><given-names>N</given-names></name><name><surname>Ahumada</surname><given-names>SM</given-names></name><name><surname>Wright</surname><given-names>LJ</given-names></name><name><surname>Mostoufi</surname><given-names>S</given-names></name><name><surname>Golnari</surname><given-names>G</given-names></name><name><surname>Reis</surname><given-names>V</given-names></name><name><surname>Cuneo</surname><given-names>JG</given-names></name></person-group>
<article-title>Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis</article-title>. <source>Psychosom Med</source>
<year>2014</year>;<volume>76</volume>:<fpage>2</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">24336429</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barski</surname><given-names>L</given-names></name><name><surname>Shafat</surname><given-names>T</given-names></name><name><surname>Buskila</surname><given-names>Y</given-names></name><name><surname>Amital</surname><given-names>H</given-names></name><name><surname>Makulin</surname><given-names>Y</given-names></name><name><surname>Shvarts</surname><given-names>B</given-names></name><name><surname>Jotkowitz</surname><given-names>A</given-names></name><name><surname>Buskila</surname><given-names>D</given-names></name></person-group>
<article-title>High prevalence of fibromyalgia syndrome among Israeli nurses</article-title>. <source>Clin Exp Rheumatol</source>
<year>2020</year>;<volume>38</volume>(<issue>suppl 1231</issue>):<fpage>25</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">31694749</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>A</given-names></name><name><surname>Rodin</surname><given-names>R</given-names></name><name><surname>Kropp</surname><given-names>R</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Hong</surname><given-names>Z</given-names></name><name><surname>Vachon</surname><given-names>J</given-names></name><name><surname>Spika</surname><given-names>J</given-names></name><name><surname>Pelletier</surname><given-names>L</given-names></name></person-group>
<article-title>Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza</article-title>. <source>CMAJ</source>
<year>2010</year>;<volume>182</volume>:<fpage>349</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">20159893</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>YT</given-names></name><name><surname>Chau</surname><given-names>PH</given-names></name><name><surname>Yip</surname><given-names>PS</given-names></name></person-group>
<article-title>A revisit on older adults suicides and Severe Acute Respiratory Syndrome (SARS) epidemic in Hong Kong</article-title>. <source>Int J Geriatr Psychiatry</source>
<year>2008</year>;<volume>23</volume>:<fpage>1231</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">18500689</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clauw</surname><given-names>D</given-names></name></person-group>
<article-title>The health consequences of the first Gulf war</article-title>. <source>BMJ</source>
<year>2003</year>;<volume>327</volume>:<fpage>1357</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">14670850</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creed</surname><given-names>F</given-names></name></person-group>
<article-title>Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2019</year>;<volume>50</volume>:<fpage>507</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">31313850</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crettaz</surname><given-names>B</given-names></name><name><surname>Marziniak</surname><given-names>M</given-names></name><name><surname>Willeke</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Hellhammer</surname><given-names>D</given-names></name><name><surname>Stumpf</surname><given-names>A</given-names></name><name><surname>Burgmer</surname><given-names>M</given-names></name></person-group>
<article-title>Stress-induced allodynia-evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress</article-title>. <source>PLoS One</source>
<year>2013</year>;<volume>8</volume>:<fpage>e69460.</fpage><pub-id pub-id-type="pmid">23950894</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eccleston</surname><given-names>C</given-names></name><name><surname>Blyth</surname><given-names>FM</given-names></name><name><surname>Dear</surname><given-names>BF</given-names></name><name><surname>Fisher</surname><given-names>EA</given-names></name><name><surname>Keefe</surname><given-names>FJ</given-names></name><name><surname>Lynch</surname><given-names>ME</given-names></name><name><surname>Palermo</surname><given-names>TM</given-names></name><name><surname>Reid</surname><given-names>MC</given-names></name><name><surname>Williams</surname><given-names>ACC</given-names></name></person-group>
<article-title>Managing patients with chronic pain during the COVID-19 outbreak: considerations for the rapid introduction of remotely supported (eHealth) pain management services</article-title>. <source>PAIN</source>
<year>2020</year>;<volume>161</volume>:<fpage>889</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">32251203</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enck</surname><given-names>P</given-names></name><name><surname>Mazurak</surname><given-names>N</given-names></name></person-group>
<article-title>The &#x0201c;Biology-First&#x0201d; Hypothesis: functional disorders may begin and end with biology-A scoping review</article-title>. <source>Neurogastroenterol Motil</source>
<year>2018</year>;<volume>30</volume>:<fpage>e13394</fpage>.<pub-id pub-id-type="pmid">29956418</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Generaal</surname><given-names>E</given-names></name><name><surname>Vogelzangs</surname><given-names>N</given-names></name><name><surname>Macfarlane</surname><given-names>GJ</given-names></name><name><surname>Geenen</surname><given-names>R</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>de Geus</surname><given-names>EJ</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name></person-group>
<article-title>Biological stress systems, adverse life events and the onset of chronic multisite musculoskeletal pain: a 6-year cohort study</article-title>. <source>Ann Rheum Dis</source>
<year>2016</year>;<volume>75</volume>:<fpage>847</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">25902791</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunduz</surname><given-names>N</given-names></name><name><surname>Usen</surname><given-names>A</given-names></name><name><surname>Aydin Atar</surname><given-names>E</given-names></name></person-group>
<article-title>The impact of perceived social support on anxiety, depression and severity of pain and burnout among Turkish females with fibromyalgia</article-title>. <source>Arch Rheumatol</source>
<year>2019</year>;<volume>34</volume>:<fpage>186</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">31497765</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halvorson</surname><given-names>HA</given-names></name><name><surname>Schlett</surname><given-names>CD</given-names></name><name><surname>Riddle</surname><given-names>MS</given-names></name></person-group>
<article-title>Postinfectious irritable bowel syndrome-a meta-analysis</article-title>. <source>AmJGastroenterol</source>
<year>2006</year>;<volume>101</volume>:<fpage>1894</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heim</surname><given-names>C</given-names></name><name><surname>Newport</surname><given-names>DJ</given-names></name><name><surname>Bonsall</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>AH</given-names></name><name><surname>Nemeroff</surname><given-names>CB</given-names></name></person-group>
<article-title>Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse</article-title>. <source>Am J Psychiatry</source>
<year>2001</year>;<volume>158</volume>:<fpage>575</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">11282691</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickie</surname><given-names>I</given-names></name><name><surname>Davenport</surname><given-names>T</given-names></name><name><surname>Wakefield</surname><given-names>D</given-names></name><name><surname>Vollmer-Conna</surname><given-names>U</given-names></name><name><surname>Cameron</surname><given-names>B</given-names></name><name><surname>Vernon</surname><given-names>SD</given-names></name><name><surname>Reeves</surname><given-names>WC</given-names></name><name><surname>Lloyd</surname><given-names>A</given-names></name></person-group>
<article-title>Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study</article-title>. <source>BMJ</source>
<year>2006</year>;<volume>333</volume>:<fpage>575</fpage>.<pub-id pub-id-type="pmid">16950834</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Currier</surname><given-names>GW</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name></person-group>
<article-title>Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year follow-up study</article-title>. <source>Gen Hosp Psychiatry</source>
<year>2009</year>;<volume>31</volume>:<fpage>546</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">19892213</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Chan</surname><given-names>MC</given-names></name><name><surname>Wu</surname><given-names>AK</given-names></name><name><surname>Ng</surname><given-names>PC</given-names></name></person-group>
<article-title>Severe acute respiratory syndrome (SARS): epidemiology and clinical features</article-title>. <source>Postgrad Med J</source>
<year>2004</year>;<volume>80</volume>:<fpage>373</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">15254300</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korosec Jagodic</surname><given-names>H</given-names></name><name><surname>Jagodic</surname><given-names>K</given-names></name><name><surname>Podbregar</surname><given-names>M</given-names></name></person-group>
<article-title>Long-term outcome and quality of life of patients treated in surgical intensive care: a comparison between sepsis and trauma</article-title>. <source>Crit Care</source>
<year>2006</year>;<volume>10</volume>:<fpage>R134</fpage>.<pub-id pub-id-type="pmid">16978417</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosciuczuk</surname><given-names>U</given-names></name><name><surname>Knapp</surname><given-names>P</given-names></name><name><surname>Lotowska-Cwiklewska</surname><given-names>AM</given-names></name></person-group>
<article-title>Opioid-induced immunosuppression and carcinogenesis promotion theories create the newest trend in acute and chronic pain pharmacotherapy</article-title>. <source>Clinics (Sao Paulo, Brazil)</source>
<year>2020</year>;<volume>75</volume>:<fpage>e1554</fpage>.</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>AM</given-names></name><name><surname>Wong</surname><given-names>JG</given-names></name><name><surname>McAlonan</surname><given-names>GM</given-names></name><name><surname>Cheung</surname><given-names>V</given-names></name><name><surname>Cheung</surname><given-names>C</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name><name><surname>Chu</surname><given-names>CM</given-names></name><name><surname>Wong</surname><given-names>PC</given-names></name><name><surname>Tsang</surname><given-names>KW</given-names></name><name><surname>Chua</surname><given-names>SE</given-names></name></person-group>
<article-title>Stress and psychological distress among SARS survivors 1 year after the outbreak</article-title>. <source>Can J Psychiatry</source>
<year>2007</year>;<volume>52</volume>:<fpage>233</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">17500304</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macfarlane</surname><given-names>GJ</given-names></name><name><surname>Kronisch</surname><given-names>C</given-names></name><name><surname>Dean</surname><given-names>LE</given-names></name><name><surname>Atzeni</surname><given-names>F</given-names></name><name><surname>Hauser</surname><given-names>W</given-names></name><name><surname>Fluss</surname><given-names>E</given-names></name><name><surname>Choy</surname><given-names>E</given-names></name><name><surname>Kosek</surname><given-names>E</given-names></name><name><surname>Amris</surname><given-names>K</given-names></name><name><surname>Branco</surname><given-names>J</given-names></name><name><surname>Dincer</surname><given-names>F</given-names></name><name><surname>Leino-Arjas</surname><given-names>P</given-names></name><name><surname>Longley</surname><given-names>K</given-names></name><name><surname>McCarthy</surname><given-names>GM</given-names></name><name><surname>Makri</surname><given-names>S</given-names></name><name><surname>Perrot</surname><given-names>S</given-names></name><name><surname>Sarzi-Puttini</surname><given-names>P</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>GT</given-names></name></person-group>
<article-title>EULAR revised recommendations for the management of fibromyalgia</article-title>. <source>Ann Rheum Dis</source>
<year>2017</year>;<volume>76</volume>:<fpage>318</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">27377815</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>IW</given-names></name><name><surname>Chu</surname><given-names>CM</given-names></name><name><surname>Pan</surname><given-names>PC</given-names></name><name><surname>Yiu</surname><given-names>MG</given-names></name><name><surname>Chan</surname><given-names>VL</given-names></name></person-group>
<article-title>Long-term psychiatric morbidities among SARS survivors</article-title>. <source>Gen Hosp Psychiatry</source>
<year>2009</year>;<volume>31</volume>:<fpage>318</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">19555791</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maunder</surname><given-names>RG</given-names></name></person-group>
<article-title>Was SARS a mental health catastrophe?</article-title>
<source>Gen Hosp Psychiatry</source>
<year>2009</year>;<volume>31</volume>:<fpage>316</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">19555790</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBeth</surname><given-names>J</given-names></name><name><surname>Chiu</surname><given-names>YH</given-names></name><name><surname>Silman</surname><given-names>AJ</given-names></name><name><surname>Ray</surname><given-names>D</given-names></name><name><surname>Morriss</surname><given-names>R</given-names></name><name><surname>Dickens</surname><given-names>C</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Macfarlane</surname><given-names>GJ</given-names></name></person-group>
<article-title>Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents</article-title>. <source>Arthritis Res Ther</source>
<year>2005</year>;<volume>7</volume>:<fpage>R992</fpage>&#x02013;<lpage>1000</lpage>.<pub-id pub-id-type="pmid">16207340</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBeth</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>K</given-names></name></person-group>
<article-title>Epidemiology of chronic musculoskeletal pain</article-title>. <source>BestPractResClinRheumatol</source>
<year>2007</year>;<volume>21</volume>:<fpage>403</fpage>&#x02013;<lpage>25</lpage>.</mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>SA</given-names></name><name><surname>Clauw</surname><given-names>DJ</given-names></name></person-group>
<article-title>Predicting chronic symptoms after an acute &#x0201c;stressor&#x0201d;-lessons learned from 3 medical conditions</article-title>. <source>MedHypotheses</source>
<year>2004</year>;<volume>63</volume>:<fpage>653</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moldofsky</surname><given-names>H</given-names></name><name><surname>Patcai</surname><given-names>J</given-names></name></person-group>
<article-title>Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study</article-title>. <source>BMC Neurol</source>
<year>2011</year>;<volume>11</volume>:<fpage>37</fpage>.<pub-id pub-id-type="pmid">21435231</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moldofsky</surname><given-names>H</given-names></name><name><surname>Scarisbrick</surname><given-names>P</given-names></name></person-group>
<article-title>Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation</article-title>. <source>Psychosomatic Med</source>
<year>1976</year>;<volume>38</volume>:<fpage>35</fpage>&#x02013;<lpage>44</lpage>.</mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohrbach</surname><given-names>R</given-names></name><name><surname>Fillingim</surname><given-names>RB</given-names></name><name><surname>Mulkey</surname><given-names>F</given-names></name><name><surname>Gonzalez</surname><given-names>Y</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Gremillion</surname><given-names>H</given-names></name><name><surname>Lim</surname><given-names>PF</given-names></name><name><surname>Ribeiro-Dasilva</surname><given-names>M</given-names></name><name><surname>Greenspan</surname><given-names>JD</given-names></name><name><surname>Knott</surname><given-names>C</given-names></name><name><surname>Maixner</surname><given-names>W</given-names></name><name><surname>Slade</surname><given-names>G</given-names></name></person-group>
<article-title>Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study</article-title>. <source>J Pain</source>
<year>2011</year>;<volume>12</volume>(<issue>11 suppl</issue>):<fpage>T27</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">22074750</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillow</surname><given-names>DR</given-names></name><name><surname>Zautra</surname><given-names>AJ</given-names></name><name><surname>Sandler</surname><given-names>I</given-names></name></person-group>
<article-title>Major life events and minor stressors: identifying mediational links in the stress process</article-title>. <source>J Personal Soc Psychol</source>
<year>1996</year>;<volume>70</volume>:<fpage>381</fpage>&#x02013;<lpage>94</lpage>.</mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajkumar</surname><given-names>RP</given-names></name></person-group>
<article-title>COVID-19 and mental health: a review of the existing literature</article-title>. <source>Asian J Psychiatr</source>
<year>2020</year>;<volume>52</volume>:<fpage>102066</fpage>.<pub-id pub-id-type="pmid">32302935</pub-id></mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raphael</surname><given-names>KG</given-names></name><name><surname>Natelson</surname><given-names>BH</given-names></name><name><surname>Janal</surname><given-names>MN</given-names></name><name><surname>Nayak</surname><given-names>S</given-names></name></person-group>
<article-title>A community-based survey of fibromyalgia-like pain complaints following the World Trade Center terrorist attacks</article-title>. <source>PAIN</source>
<year>2002</year>;<volume>100</volume>:<fpage>131</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">12435466</pub-id></mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapolsky</surname><given-names>RM</given-names></name></person-group>
<article-title>Why stress is bad for your brain</article-title>. <source>Science</source>
<year>1996</year>;<volume>273</volume>:<fpage>749</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">8701325</pub-id></mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schelling</surname><given-names>G</given-names></name><name><surname>Stoll</surname><given-names>C</given-names></name><name><surname>Haller</surname><given-names>M</given-names></name><name><surname>Briegel</surname><given-names>J</given-names></name><name><surname>Manert</surname><given-names>W</given-names></name><name><surname>Hummel</surname><given-names>T</given-names></name><name><surname>Lenhart</surname><given-names>A</given-names></name><name><surname>Heyduck</surname><given-names>M</given-names></name><name><surname>Polasek</surname><given-names>J</given-names></name><name><surname>Meier</surname><given-names>M</given-names></name><name><surname>Preuss</surname><given-names>U</given-names></name><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>Schuffel</surname><given-names>W</given-names></name><name><surname>Peter</surname><given-names>K</given-names></name></person-group>
<article-title>Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome</article-title>. <source>Crit Care Med</source>
<year>1998</year>;<volume>26</volume>:<fpage>651</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">9559601</pub-id></mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sheehy</surname><given-names>LM</given-names></name></person-group>
<source>Considerations for post-acute rehabilitation for survivors of COVID-19</source>. <publisher-loc>Ottawa, Ontario, Canada</publisher-loc>: <publisher-name>JMIR public health and surveillance</publisher-name>, <year>2020</year>.</mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Kanazawa</surname><given-names>M</given-names></name><name><surname>Fukudo</surname><given-names>S</given-names></name><name><surname>Drossman</surname><given-names>DA</given-names></name></person-group>
<article-title>Biopsychosocial model of irritable bowel syndrome</article-title>. <source>J Neurogastroenterol Motil</source>
<year>2011</year>;<volume>17</volume>:<fpage>131</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21602989</pub-id></mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="book"><collab>The Centre for Evidence-Based Medicine</collab>. <source>Global covid-19 case fatality rates</source>, <year>2020</year> Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates">https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates</ext-link>. Accessed 6 May 2020.</mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmers</surname><given-names>TK</given-names></name><name><surname>Verhofstad</surname><given-names>MH</given-names></name><name><surname>Moons</surname><given-names>KG</given-names></name><name><surname>van Beeck</surname><given-names>EF</given-names></name><name><surname>Leenen</surname><given-names>LP</given-names></name></person-group>
<article-title>Long-term quality of life after surgical intensive care admission</article-title>. <source>Arch Surg</source>
<year>2011</year>;<volume>146</volume>:<fpage>412</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">21173281</pub-id></mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uceyler</surname><given-names>N</given-names></name><name><surname>Burgmer</surname><given-names>M</given-names></name><name><surname>Friedel</surname><given-names>E</given-names></name><name><surname>Greiner</surname><given-names>W</given-names></name><name><surname>Petzke</surname><given-names>F</given-names></name><name><surname>Sarholz</surname><given-names>M</given-names></name><name><surname>Schiltenwolf</surname><given-names>M</given-names></name><name><surname>Winkelmann</surname><given-names>A</given-names></name><name><surname>Sommer</surname><given-names>C</given-names></name><name><surname>Hauser</surname><given-names>W</given-names></name></person-group>
<article-title>Etiology and pathophysiology of fibromyalgia syndrome: updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups</article-title>. <source>Schmerz (Berlin, Germany)</source>
<year>2017</year>;<volume>31</volume>:<fpage>239</fpage>&#x02013;<lpage>45</lpage>.</mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Houdenhove</surname><given-names>B</given-names></name><name><surname>Egle</surname><given-names>UT</given-names></name></person-group>
<article-title>Fibromyalgia: a stress disorder? Piecing the biopsychosocial puzzle together</article-title>. <source>Psychother Psychosom</source>
<year>2004</year>;<volume>73</volume>:<fpage>267</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">15292624</pub-id></mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van West</surname><given-names>D</given-names></name><name><surname>Maes</surname><given-names>M</given-names></name></person-group>
<article-title>Neuroendocrine and immune aspects of fibromyalgia</article-title>. <source>Biodrugs</source>
<year>2001</year>;<volume>15</volume>:<fpage>521</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">11543693</pub-id></mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verity</surname><given-names>R</given-names></name><name><surname>Okell</surname><given-names>LC</given-names></name><name><surname>Dorigatti</surname><given-names>I</given-names></name><name><surname>Winskill</surname><given-names>P</given-names></name><name><surname>Whittaker</surname><given-names>C</given-names></name><name><surname>Imai</surname><given-names>N</given-names></name><name><surname>Cuomo-Dannenburg</surname><given-names>G</given-names></name><name><surname>Thompson</surname><given-names>H</given-names></name><name><surname>Walker</surname><given-names>PGT</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Dighe</surname><given-names>A</given-names></name><name><surname>Griffin</surname><given-names>JT</given-names></name><name><surname>Baguelin</surname><given-names>M</given-names></name><name><surname>Bhatia</surname><given-names>S</given-names></name><name><surname>Boonyasiri</surname><given-names>A</given-names></name><name><surname>Cori</surname><given-names>A</given-names></name><name><surname>Cucunuba</surname><given-names>Z</given-names></name><name><surname>FitzJohn</surname><given-names>R</given-names></name><name><surname>Gaythorpe</surname><given-names>K</given-names></name><name><surname>Green</surname><given-names>W</given-names></name><name><surname>Hamlet</surname><given-names>A</given-names></name><name><surname>Hinsley</surname><given-names>W</given-names></name><name><surname>Laydon</surname><given-names>D</given-names></name><name><surname>Nedjati-Gilani</surname><given-names>G</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>van Elsland</surname><given-names>S</given-names></name><name><surname>Volz</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xi</surname><given-names>X</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name><name><surname>Ghani</surname><given-names>AC</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name></person-group>
<article-title>Estimates of the severity of coronavirus disease 2019: a model-based analysis</article-title>. <source>Lancet Infect Dis</source>
<year>2020</year>;<volume>20</volume>:<fpage>669</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">32240634</pub-id></mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>JW</given-names></name><name><surname>Brown</surname><given-names>V</given-names></name><name><surname>Jacobs</surname><given-names>S</given-names></name><name><surname>Horne</surname><given-names>L</given-names></name><name><surname>Langenberg</surname><given-names>P</given-names></name><name><surname>Greenberg</surname><given-names>P</given-names></name></person-group>
<article-title>Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome</article-title>. <source>Urology</source>
<year>2008</year>;<volume>71</volume>:<fpage>1085</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">18538691</pub-id></mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessely</surname><given-names>S</given-names></name><name><surname>Chalder</surname><given-names>T</given-names></name><name><surname>Hirsch</surname><given-names>S</given-names></name><name><surname>Pawlikowska</surname><given-names>T</given-names></name><name><surname>Wallace</surname><given-names>P</given-names></name><name><surname>Wright</surname><given-names>DJ</given-names></name></person-group>
<article-title>Postinfectious fatigue: prospective cohort study in primary care</article-title>. <source>Lancet</source>
<year>1995</year>;<volume>345</volume>:<fpage>1333</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">7752755</pub-id></mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="other"><collab>World Health Organization</collab>. <source>Mental health and psychosocial considerations during the COVID-19 outbreak 2020</source>.. Available at <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/331490/WHO-2019-nCoV-MentalHealth-2020.1-eng.pdf">https://apps.who.int/iris/bitstream/handle/10665/331490/WHO-2019-nCoV-MentalHealth-2020.1-eng.pdf</ext-link>. Accessed 15 May 2020.</mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group>
<article-title>A meta-analysis of risk factors for combat-related PTSD among military personnel and veterans</article-title>. <source>PLoS One</source>
<year>2015</year>;<volume>10</volume>:<fpage>e0120270</fpage>.<pub-id pub-id-type="pmid">25793582</pub-id></mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yavne</surname><given-names>Y</given-names></name><name><surname>Amital</surname><given-names>D</given-names></name><name><surname>Watad</surname><given-names>A</given-names></name><name><surname>Tiosano</surname><given-names>S</given-names></name><name><surname>Amital</surname><given-names>H</given-names></name></person-group>
<article-title>A systematic review of precipitating physical and psychological traumatic events in the development of fibromyalgia</article-title>. <source>Semin Arthritis Rheum</source>
<year>2018</year>;<volume>48</volume>:<fpage>121</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">29428291</pub-id></mixed-citation></ref></ref-list></back></article>